DUBLIN--(BUSINESS WIRE)--The "Global Polymerase Chain Reaction Technologies Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The Polymerase Chain Reaction Technologies Market was valued at $7 billion in 2016, and is estimated to reach $11 billion by 2023, growing at a CAGR of 6.9% during the forecast period.
Growing geriatric population, growing prevalence of infectious diseases, rapidly growing diagnostic centers and hospitals, technological advancements, and growing awareness and acceptance of personalized medicine are the factors that drive the polymerase chain reaction technologies market.
Nevertheless, growing non-validated home-brew tests and reimbursement issues are the factors that limit the growth of the market. Also, accurate and timely results for RT-PCR would further add to the challenges to the polymerase chain reaction technologies growth.
Less tedious processes open avenues for the PCR market. Additionally, increasing funding towards research and development activities and large untapped markets in developing regions would further add to the market opportunities during the forecast period.
The report covers the analysis of key stake holders of the Global Polymerase Chain Reaction Technologies Market. Key companies profiled in the report include Agilent Technologies, BioMrieux, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, Fluidigm Corporation, LGC Limited, Qiagen NV, SYGNIS Pharma AG, Takara Bio, Inc., and Thermo Fisher Scientific.
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. Global Polymerase Chain Reaction Technologies Market
4. Global Polymerase Chain Reaction Technologies Market by Product
5. Global Polymerase Chain Reaction Technologies Market by End User
6. Global Polymerase Chain Reaction Technologies Market by Application
7. Global Polymerase Chain Reaction Technologies Market by Region
8. Company Profiles
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd
- Fluidigm Corporation
- LGC Limited
- Qiagen NV
- SYGNIS Pharma AG
- Takara Bio, Inc.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/8dzd6l/global_polymerase?w=4